Remove tag content-metrics
article thumbnail

Cartherics grants licence for CTH-004 to Shunxi

Pharmaceutical Technology

CTH-004 is developed by genetically altering patient T cells for inserting a chimeric antigen receptor (CAR) to target a marker (TAG-72) on ovarian cancer cells and delete genes which are involved in T cell function suppression. Editorial content is independently produced and follows the highest standards of journalistic integrity.

article thumbnail

Upcoming sickle cell gene therapies cost effective at $2 million, says ICER

Pharmaceutical Technology

Although the findings in the report are only preliminary, they shed light at the considerations behind the high price tags of gene therapies. ICER uses quality-adjusted life year (QALY), a cost effectiveness metric to measure the value of a healthcare intervention. Topic sponsors are not involved in the creation of editorial content.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Q&A: A decade on, what’s next for CAR-T therapies?

Pharmaceutical Technology

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. Editorial content is independently produced and follows the highest standards of journalistic integrity. Topic sponsors are not involved in the creation of editorial content.

article thumbnail

iOS 15 Update: Mail Privacy Protection

Intouch Solutions

Despite these metrics, we are not seeing the impact on apps offering advertising services. As a result, tracking open rates, geo-location, and real-time content personalization such as countdown timers, for example, will no longer be available for those users.

article thumbnail

Ep. 008 – Vlad Mkrtumyan Podcast Transcript

Pharma Marketing Network

Number one, there’s the content right, so when you’re searching coffee internet you’re reading something some kind of content and that’s the first thing you’ve got to create and optimize the second thing the second component besides content is link building, right?

Doctors 52
article thumbnail

CSL doses first patient with haemophilia B gene therapy Hemgenix

Pharmaceutical Technology

The high price tag may be hard to defend , but with lifetime treatment costs for haemophilia B reaching as high as $23m for some, the single-dose treatment could prove far more cost-effective. Despite the limited market, the price tags of haemophilia make it potentially lucrative. Haemophilia B is a rare condition.

article thumbnail

Moving to component management & traceability: progress, barriers, and the way forward

pharmaphorum

Component management is fairly new to the regulatory market, with pharmaceutical firms moving from traditional document management systems to more dynamic component content management systems. The traceability of components is critical for authoring structured content correctly, especially when it comes to fulfilling compliance regulations.